Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to Trading

1 May 2015 07:00

RNS Number : 9172L
Ranger Direct Lending Fund PLC
01 May 2015
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

1 May 2015

 

Ranger Direct Lending Fund plc

Admission to Trading on the London Stock Exchange

Ranger Direct Lending Fund plc is pleased to announce that its ordinary share capital consisting of 13,500,000 ordinary shares are expected to be admitted to the premium listing segment of the Official List of the UK Listing Authority, and to trading on the London Stock Exchange's main market for listed securities, at 8.00am today under the ticker "RDL".

 

Ranger Alternative Management II, LPScott Canon

Bill Kassul

 

via Redleaf PR

Liberum

Simon Atkinson

Tom Fyson

Joshua Hughes

 

+44 (0)20 3100 2000

Media enquiries

 

Redleaf Polhill

Rebecca Sanders-Hewett

David Ison

 

+44 (0)20 7382 4730

Intermediary Offer enquiries:

Scott Harris

Jeremy Wiseman

Jamie Blewitt

 

+44 (0)20 7653 0030

IMPORTANT INFORMATION

Liberum is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Liberum or advice to any other person in relation to the matters contained herein.

Neither Liberum nor any of its directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of, the information in this announcement (or whether any information has been omitted from the announcement) or any information relating to the Company, whether written, oral, or in a visual or electronic form, and howsoever transmitted or made available or any loss howsoever arising from any use of this announcement or its contents or otherwise in connection with it.

This announcement may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. Securities may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The securities mentioned herein have not been, and will not be, registered under the Securities Act and will not be offered to the public in the United States. The Company has not been, and will not be, registered under the US Investment Company Act of 1940, as amended.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSDWFISFISEFL
Date   Source Headline
3rd Nov 20173:45 pmRNSNet Asset Value(s)
3rd Nov 20173:45 pmRNSMonthly Update
1st Nov 20177:00 amRNSStrategic Partner Discussions
23rd Oct 20172:14 pmRNSPortfolio Update
9th Oct 20174:35 pmRNSMonthly Update
9th Oct 20174:34 pmRNSNet Asset Value(s)
26th Sep 20177:00 amRNSHalf-year Report
15th Sep 20174:35 pmRNSPrice Monitoring Extension
13th Sep 20174:34 pmRNSMonthly Update
13th Sep 20174:32 pmRNSNet Asset Value(s)
14th Aug 20174:05 pmRNSHolding(s) in Company
11th Aug 20173:17 pmRNSDividend Declaration
9th Aug 20172:43 pmRNSHolding(s) in Company
8th Aug 20174:47 pmRNSHolding(s) in Company
7th Aug 20172:40 pmRNSHolding(s) in Company
4th Aug 20178:45 amRNSMonthly Update
4th Aug 20178:45 amRNSNet Asset Value(s)
31st Jul 20174:33 pmRNSHolding(s) in Company
26th Jul 20172:56 pmRNSDirector/PDMR Shareholding
12th Jul 20173:19 pmRNSHolding(s) in Company
12th Jul 20173:19 pmRNSHolding(s) in Company
30th Jun 20173:09 pmRNSMonthly Update
30th Jun 20173:07 pmRNSNet Asset Value(s)
29th Jun 20173:51 pmRNSHolding(s) in Company
28th Jun 20173:43 pmRNSHolding(s) in Company
26th Jun 20174:01 pmRNSDirector/PDMR Shareholding
26th Jun 20174:01 pmRNSDirector/PDMR Shareholding
26th Jun 20177:00 amRNSCorporate Update
22nd Jun 20174:59 pmRNSDirector/PDMR Shareholding
22nd Jun 20173:05 pmRNSDirector/PDMR Shareholding
16th Jun 20175:05 pmRNSDirector/PDMR Shareholding
16th Jun 20174:25 pmRNSDirector/PDMR Shareholding
16th Jun 20174:20 pmRNSDividend Declaration
15th Jun 20175:19 pmRNSDirector/PDMR Shareholding
15th Jun 20175:07 pmRNSResult of AGM
15th Jun 20177:00 amRNSCorporate Update
2nd Jun 20173:39 pmRNSPublication of a Supplementary Prospectus
26th May 20175:35 pmRNSMonthly Update
26th May 20175:28 pmRNSNet Asset Value(s)
23rd May 20175:34 pmRNSDirector/PDMR Shareholding
18th May 20174:13 pmRNSHolding(s) in Company
17th May 20172:29 pmRNSPortfolio Update
15th May 20172:18 pmRNSMonthly Update
12th May 20177:00 amRNSNet Asset Value(s)
2nd May 20174:38 pmRNSTotal Voting Rights
28th Apr 20174:15 pmRNSAnnual Financial Report
12th Apr 20177:00 amRNSPortfolio update - Argon Credit
7th Apr 20172:47 pmRNSDirector/PDMR Shareholding
7th Apr 20177:00 amRNSAdmission to the Official List
31st Mar 20174:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.